ConductScience.org, home

Paper21692829

Effect of grapefruit juice on the pharmacokinetics of docetaxel in cancer patients: a case report.

Valenzuela B and 4 others. Br J Clin Pharmacol, 2011. Cited by 15 papers, by iCite.

Cite this record

ConductScience Library. Effect of grapefruit juice on the pharmacokinetics of docetaxel in cancer patients: a case report. Papers, record 21692829. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21692829

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effect of grapefruit juice on the pharmacokinetics of docetaxel in cancer patients: a case report.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
2011
PubMed
Publication types
Case Reports, Letter
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
0.59
iCite
Revised in PubMed
2021-10-20
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Valenzuela BBelén
2Rebollo JJoseba
3Pérez TTania
4Brugarolas AAntonio
5Pérez-Ruixo JJJuan José

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Citrus paradisiMajor topic
Food-Drug InteractionsMajor topic
TaxoidsMajor topic
Beverages
Carcinoma, Squamous Cell
Cytochrome P-450 CYP3A
Cytochrome P-450 CYP3A Inhibitors
Docetaxel
Esophageal Neoplasms
Female
Humans
Middle Aged

Source PubMed

Download CSV of topics

References21

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110778948The effect of an individual's cytochrome CYP3A4 activity on docetaxel clearance.Clin Cancer Res2000https://conductscience.org/library/papers/10778948PubMed
220573082Population pharmacokinetics of intravenously and orally administered docetaxel with or without co-administration of ritonavir in patients with advanced cancer.Br J Clin Pharmacol2010https://conductscience.org/library/papers/20573082PubMed
311768292Ways to fit a PK model with some data below the quantification limit.J Pharmacokinet Pharmacodyn2001https://conductscience.org/library/papers/11768292PubMed
49654116Evaluation of the linearity of docetaxel pharmacokinetics.Cancer Chemother Pharmacol1998https://conductscience.org/library/papers/9654116PubMed
520430905Pharmacokinetics and pharmacodynamics of docetaxel with or without ketoconazole modulation in chemonaive breast cancer patients.Ann Oncol2010https://conductscience.org/library/papers/20430905PubMed
69440742Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancer.J Clin Oncol1998https://conductscience.org/library/papers/9440742PubMed
715116057Effect of cytochrome P450 3A4 inhibition on the pharmacokinetics of docetaxel.Clin Pharmacol Ther2004https://conductscience.org/library/papers/15116057PubMed
812953340Exposure-dependent inhibition of intestinal and hepatic CYP3A4 in vivo by grapefruit juice.J Clin Pharmacol2003https://conductscience.org/library/papers/12953340PubMed
99815840Optimal sampling strategies for bayesian estimation of docetaxel (Taxotere) clearance.Clin Cancer Res1997https://conductscience.org/library/papers/9815840PubMed
1016628131Determination of docetaxel and Paclitaxel in human plasma by high-performance liquid chromatography: validation and application to clinical pharmacokinetic studies.Ther Drug Monit2006https://conductscience.org/library/papers/16628131PubMed
117907950Pharmacokinetics and metabolism of Taxotere (docetaxel).Cancer Surv1993https://conductscience.org/library/papers/7907950PubMed
1215041715Comparative pharmacokinetics of weekly and every-three-weeks docetaxel.Clin Cancer Res2004https://conductscience.org/library/papers/15041715PubMed
1316509758Clinical pharmacokinetics of docetaxel : recent developments.Clin Pharmacokinet2006https://conductscience.org/library/papers/16509758PubMed
1417956601Pharmacokinetic analysis of two different docetaxel dose levels in patients with non-small cell lung cancer treated with docetaxel as monotherapy or with concurrent radiotherapy.BMC Cancer2007https://conductscience.org/library/papers/17956601PubMed
1521224369Therapeutic drug monitoring for the individualization of docetaxel dosing: a randomized pharmacokinetic study.Clin Cancer Res2011https://conductscience.org/library/papers/21224369PubMed
168875345A population pharmacokinetic model for docetaxel (Taxotere): model building and validation.J Pharmacokinet Biopharm1996https://conductscience.org/library/papers/8875345PubMed
1711180028Clinical trial simulation of docetaxel in patients with cancer as a tool for dosage optimization.Clin Pharmacol Ther2000https://conductscience.org/library/papers/11180028PubMed
1819924122Intravenous-to-oral switch in anticancer chemotherapy: a focus on docetaxel and paclitaxel.Clin Pharmacol Ther2010https://conductscience.org/library/papers/19924122PubMed
1915585753Model describing the relationship between pharmacokinetics and hematologic toxicity of the epirubicin-docetaxel regimen in breast cancer patients.J Clin Oncol2005https://conductscience.org/library/papers/15585753PubMed
2019920203Absence of both cytochrome P450 3A and P-glycoprotein dramatically increases docetaxel oral bioavailability and risk of intestinal toxicity.Cancer Res2009https://conductscience.org/library/papers/19920203PubMed

See all 21 referencesDownload CSV of references

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
41002089[Breast cancer survivor program: follow-up, rehabilitation, psycho-oncology, palliative care].Magy Onkol2025https://conductscience.org/library/papers/41002089PubMed
40507996Hazardous Interactions Between Food, Herbs, and Drugs in the First Stage of Biotransformation: Case Reports of Adverse Drug Interactions in Humans.Int J Mol Sci2025https://conductscience.org/library/papers/40507996PubMed
39386271Individual pharmacokinetic parameter estimation of gentamicin in an obese hemodialysis patient using non-linear mixed effect model.Transl Clin Pharmacol2024https://conductscience.org/library/papers/39386271PubMed
36493603Cytochrome P-450-mediated herb and food-drug interactions can be identified in cancer patients through patient self-reporting with a tablet application: results of a prospective observational study.ESMO Open2022https://conductscience.org/library/papers/36493603PubMed
35568834A comprehensive evaluation of potentially significant drug-drug, drug-herb, and drug-food interactions among cancer patients receiving anticancer drugs.BMC Cancer2022https://conductscience.org/library/papers/35568834PubMed
31850232Herbal Interaction With Chemotherapeutic Drugs-A Focus on Clinically Significant Findings.Front Oncol2019https://conductscience.org/library/papers/31850232PubMed
29667038Complex Drug-Drug-Gene-Disease Interactions Involving Cytochromes P450: Systematic Review of Published Case Reports and Clinical Perspectives.Clin Pharmacokinet2018https://conductscience.org/library/papers/29667038PubMed
28814868Nano-sized cytochrome P450 3A4 inhibitors to block hepatic metabolism of docetaxel.Int J Nanomedicine2017https://conductscience.org/library/papers/28814868PubMed
28261555Food and Drug Interactions.J Lifestyle Med2017https://conductscience.org/library/papers/28261555PubMed
23673492Is pomegranate juice a potential perpetrator of clinical drug-drug interactions? Review of the in vitro, preclinical and clinical evidence.Eur J Drug Metab Pharmacokinet2013https://conductscience.org/library/papers/23673492PubMed
22884524Mechanisms underlying food-drug interactions: inhibition of intestinal metabolism and transport.Pharmacol Ther2012https://conductscience.org/library/papers/22884524PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CYP3A41576PubTator's text mininghttps://conductscience.org/library/genes/1576

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21692829

GET https://conductscience.org/api/papers/v1/21692829/references?page=2